Literature DB >> 8807231

Adverse effects of cosmetics and toiletries reported to the Swedish Medical Products Agency 1989-1994.

B Berne1, A Boström, A F Grahnén, M Tammela.   

Abstract

In Sweden, a cosmetic control system was introduced in 1989 at the Medical Products Agency (MPA). It consists of a register of importers, manufacturers and their products, and a voluntary adverse reaction reporting system identical to that concerning drugs. Between 1989 and 1994, MPA evaluated 191 reports concerning adverse effects of 253 cosmetics and toiletries. 90% of the reports concerned women and the top-ranking product category was moisturizers, followed by hair care products and nail products. The majority of the adverse effects reported involved only the skin, and 90% were eczematous reactions. 70% of the eczemas were classified as contact allergic, as patch tests were positive to the product as is, and in 1/2 of these products, 1 or more relevant allergens could be identified when tests were made with individual cosmetic ingredients. The most common offending ingredients were fragrances, toluenesulfonamide-formaldehyde resin and preservatives. The number of reports is small in relation to the expected number of cosmetic adverse effects, which can be explained by under-reporting. Efforts are being made to persuade Swedish physicians to report more often.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807231     DOI: 10.1111/j.1600-0536.1996.tb02223.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  2 in total

1.  Understanding the adverse effects of cosmetics: a pilot project in cosmetovigilance.

Authors:  Lidia Sautebin
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

2.  Adverse cutaneous reactions to skin care products on the face vary with age, but not with sex.

Authors:  Li-Ning Huang; Yi-Ping Zhong; Dan Liu; Xiao-Hua Wang; Can-Yi Gong; Si Wen; Peter M Elias; Bin Yang; Mao-Qiang Man
Journal:  Contact Dermatitis       Date:  2018-09-12       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.